Philipp Knebel

Anti-angiogenic activity of VXM01, an oral T-cell vaccine against VEGF receptor 2, in patients with advanced pancreatic cancer: A randomized, placebo-controlled, phase 1 trial

Friedrich H. Schmitz-Winnenthal, Nicolas Hohmann, Andreas G. Niethammer et al. · OncoImmunology · 2015 · 75 citations · Full text

Medicine, Immunology, Oncology +17

Double-blind, placebo-controlled first in human study to investigate an oral vaccine aimed to elicit an immune reaction against the VEGF-Receptor 2 in patients with stage IV and locally advanced pancreatic cancer

Andreas G. Niethammer, Heinz Lubenau, Gerd Mikus et al. · BMC Cancer · 2012 · 58 citations · Full text

Medicine, Immunology, Oncology +17

Complications after end-to-end vs. side-to-side anastomosis in ileocecal Crohn’s disease—early postoperative results from a randomized controlled multi-center trial (ISRCTN-45665492)

Urte Zurbuchen, Anton J. Kroesen, Philipp Knebel et al. · Langenbeck s Archives of Surgery · 2012 · 44 citations

Medicine, Clinical Sciences, Surgery +15

Evaluation of robotic versus open partial pancreatoduodenectomy—study protocol for a randomised controlled pilot trial (EUROPA, DRKS00020407)

Rosa Klotz, Colette Dörr-Harim, Thomas Brückner et al. · Trials · 2021 · 23 citations · Full text

Medicine, Oncology, Surgery +17

Minimally Invasive Versus open AbdominoThoracic Esophagectomy for esophageal carcinoma (MIVATE) — study protocol for a randomized controlled trial DRKS00016773

Felix Nickel, Pascal Probst, Alexander Studier‐Fischer et al. · Trials · 2021 · 16 citations · Full text

Medicine, Oncology, Surgery +13